Navigation Links
Igenica Appoints Mary Haak-Frendscho, Ph.D., as Chief Executive Officer
Date:9/18/2012

BURLINGAME, Calif., Sept. 18, 2012 /PRNewswire/ -- Igenica, Inc., a leading biopharmaceutical company focused on the discovery and development of first-in-class cancer antibody therapeutics, today announced the appointment of Mary Haak-Frendscho, Ph.D., to the role of Chief Executive Officer and member of the Board of Directors. Dr. Haak-Frendscho succeeds David Goeddel, Ph.D., who remains as Igenica's Chairman of the Board.

Dr. Haak-Frendscho brings more than twenty years of experience in building robust biotechnology organizations for the discovery and development of novel therapeutic antibodies. Dr. Haak-Frendscho joins Igenica from Takeda, where she served as founding President and Chief Scientific Officer of Takeda San Francisco, establishing and overseeing Takeda's Center of Excellence for antibody biologics. Prior to Takeda, Dr. Haak-Frendscho held positions of increasing responsibility at XOMA, Abgenix and Genentech, where she secured collaborative relationships with external corporate partners, led antibody programs, and played a key role in the development of omalizumab (Xolair®, Genentech/ Novartis).  An immunologist by training, Dr. Haak-Frendscho holds degrees from the University of Michigan,Washington University, Stony Brook University (S.U.N.Y.), and the University of Wisconsin.

"Dr. Haak-Frendscho brings an exceptional range of experience and skills spanning antibody drug discovery and development, operations, strategic alliances and executive management," said Dr. Goeddel. "Her team-oriented approach will serve Igenica well as it transitions into its next stage of growth."

"I am delighted to be joining Igenica at this pivotal time in the company's history," said Dr. Haak-Frendscho.  "With strong support from The Column Group, 5AM Ventures, Orbimed Advisors and Third Rock Ventures, Igenica is well-positioned to be a powerhouse in target and antibody discovery exemplified by an exciting lead program, established discovery platforms and superb management team and scientific staff."

About Igenica, Inc.
Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative technology platforms to address the major challenges to developing effective treatments for multiple oncology indications, with sTAg, a new approach to discovering and prioritizing novel tumor antigens, and iTAb, a functional in vivo antibody screening approach. Collectively, the two technology platforms drive Igenica's drug discovery efforts and promise to identify novel and more effective cancer therapeutics.

Igenica's Board of Directors includes David Goeddel, Ph.D., Managing Partner, The Column Group; John Diekman, Ph.D., Managing Partner, 5AM Ventures; Mark A. Goldsmith, M.D., Ph.D., Venture Partner, Third Rock Ventures; Carl Gordon, Ph.D., CFA, General Partner, Orbimed Advisors; Robert Schreiber, Ph.D., Alumni Endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology and Tumor Immunology Program Leader for the Siteman Comprehensive Cancer Center at Washington University School of Medicine.

Contact:

John K. Celebi, MBA
Chief Business Officer
Igenica, Inc.
(650) 231-4320


'/>"/>
SOURCE Igenica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Igenica Closes $33 Million in Series C Funding
2. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
3. Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
4. Pharmalink Consulting Appoints Chief Operating Officer for the Americas
5. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
6. EvaluatePharma Appoints Alexander Karle as COO
7. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
8. Insmed Appoints Will Lewis as President and Chief Executive Officer
9. Circassia Appoints Dr Brett Haumann as Chief Medical Officer
10. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
11. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... -- The innovator of COMBO ... s first dual therapy stent, introduces catheters for lower ... a global company specializing in the provision of life-changing ... to treat peripheral artery disease. The JADE™ and Scoreflex™ ... lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... May 24, 2016 Dutch surgeons have launched ... around the world and treat patients on a global scale. Medical ... , Asia and the US have already ... messaging and networking in a totally secure environment. Education  ... war zone working together with a surgeon at Harvard to treat ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... medicine. Allison Outerbridge is this year’s Life University winner of a ... the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter ...
(Date:5/26/2016)... ... 26, 2016 , ... Cabot Corporation, Pfizer, and 3M are ... court documents and SEC filings. A jury has returned a verdict of ... Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm ... Dr. Maisel, founder of Retina Group of New York , is a ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eating Recovery Center, Washington ... opening a brand new child and adolescent residential treatment center on June 1. ... even more specialized eating disorder treatment and access to life-saving care. , To ...
Breaking Medicine News(10 mins):